01283nam--2200409---450-99000322005020331620090417102915.0978-88-598-0325-6000322005USA01000322005(ALEPH)000322005USA0100032200520090417h2008----km-y0itay0103----baitaITa---||||001yyElementi e parti dell'edificioRudolf Luckmannedizione italiana a cura di Mauro Sudano e Davide FerreroTorinoUTET Scienze tecnichecopyr. 2008VIII, 355 p.ill.30 cm1 CD-ROMDettagli di progettazione1Tit. orig.: Baudetail AtlasTrad. dal tedesco: Duccio Biasi2001Dettagli di progettazione1Baudetail AtlasProgettazione architettonicaBNCF721LÜCKMANN,JensRudolf603642SUDANO,MauroFERRERO,DavideITsalbcISBD990003220050203316721 LUC62680 G.72100206595BKTECIANNONE9020090417USA011029Elementi e parti dell'edificio1011315UNISA03754nam 2200985z- 450 991055738040332120220111(CKB)5400000000042095(oapen)https://directory.doabooks.org/handle/20.500.12854/76432(oapen)doab76432(EXLCZ)99540000000004209520202201d2021 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierImmunohistochemical ExpressionBasel, SwitzerlandMDPI - Multidisciplinary Digital Publishing Institute20211 online resource (168 p.)3-0365-0400-1 3-0365-0401-X Immunohistochemistry (IHC) is an ancillary method, widely used in pathologists' practice, that allows identifying diagnostic and prognostic/predictive of therapeutic response protein markers on tissue samples by the use of specific monoclonal antibodies and chromogenic substances that guarantee the visualization of an antibody-antigene binding complex under a light microscope [1]. Coon et al., in 1941 [2], first introduced the use of fluorochrome-conjugated antibodies in clinical practice. Since then, IHC has gone from being a useful tool for identifying the differentiation line of otherwise undifferentiated cells to a technique capable of providing not only diagnostic but also prognostic and predictive indications of responses to specific therapeutic options [1,3]. The abovementioned peculiarities have made IHC one of the most used ancillary methods in the histopathological approach to human neoplastic and non-neoplastic diseases [3-5]. This Special Issue contains 11 accepted papers that provide readers with a comprehensive update on current and future applications of IHC in medical practice.MedicinebicsscABCB5c-kitcarcinogenesischaperonopathiescytokeratinDENdifferential diagnosisEGCGenteric nervous systemexcretion fraction of uric acidfollicular adenomafollicular carcinomaheartHsp27Hsp60Hsp70Hsp90human embryonal/fetal tissueshypouricemiaimmunohistochemistryinflammationinitial lymphaticskidneylivermacroH2Amatrix metalloproteinasesmegacystismetastasismolecular chaperonen/aneoplastic tissueNGALoutcome and prognosisoxidative stressPDGFRpericardiumprognosisprognostic factorprostate cancerSLC22A12temporomandibular jointtemporomandibular joint disorderthyroidtraining exerciseultra-structural changesURAT1uric acid transportersurinary tract malformationsuveal melanomaVDRVitamin DWT1MedicineCaltabiano Rosarioedt1314843Loreto CarlaedtCaltabiano RosarioothLoreto CarlaothBOOK9910557380403321Immunohistochemical Expression3032037UNINA